Catherine Novack
Stock Analyst at Jones Trading
(0.44)
# 2417
Out of 5,328 analysts
23
Total ratings
33.33%
Success rate
-1.02%
Average return
Main Sectors:
Top Industries:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
RGLS Regulus Therapeutics | Downgrades: Hold | 8 7 | 7.86 | -10.94% | 2 | Apr 30, 2025 | |
RLYB Rallybio | Downgrades: Hold | n/a | n/a | n/a | 1 | Apr 15, 2025 | |
PVLA Palvella Therapeutic... | Initiates Coverage On: Buy | 45 | 23.85 | 88.68% | 1 | Mar 25, 2025 | |
PRQR ProQR Therapeutics | Initiates Coverage On: Buy | 11 | 1.73 | 535.84% | 1 | Feb 12, 2025 | |
KRRO Korro Bio | Initiates Coverage On: Buy | 130 | 18.11 | 617.84% | 1 | Nov 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 40 | 12.88 | 210.56% | 1 | Nov 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Nov 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Oct 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 12 16 | 7.96 | 101.01% | 2 | Sep 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 14 | 2.85 | 391.23% | 1 | Sep 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 5 13 | 2.96 | 339.19% | 2 | Aug 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 3.96 | 152.53% | 1 | Apr 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 7 10 | 1.18 | 747.46% | 1 | Mar 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 22 | 1.55 | 1319.35% | 1 | Feb 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 2 | Oct 5, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 160 | 2.39 | 6594.56% | 1 | Jul 21, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 11 | n/a | n/a | 1 | Mar 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 25 | n/a | n/a | 1 | Dec 2, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 45 | n/a | n/a | 1 | Oct 4, 2021 |